Author: Jessica Flanigan
Publisher: Oxford University Press
ISBN: 0190684542
Category : Law
Languages : en
Pages : 289
Get Book Here
Book Description
Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.
Author: Jessica Flanigan
Publisher: Oxford University Press
ISBN: 0190684550
Category : Philosophy
Languages : en
Pages : 289
Get Book Here
Book Description
If a competent adult refuses medical treatment, physicians and public officials must respect her decision. Coercive medical paternalism is a clear violation of the doctrine of informed consent, which protects patients' rights to make medical decisions even if a patient's choice endangers her health. The same reasons for rejecting medical paternalism in the doctor's office are also reasons to reject medical paternalism at the pharmacy, yet coercive medical paternalism persists in the form of premarket approval policies and prescription requirements for pharmaceuticals. In Pharmaceutical Freedom Jessica Flanigan defends patients' rights of self-medication. Flanigan argues that public officials should certify drugs instead of enforcing prohibitive pharmaceutical policies that disrespect people's rights to make intimate medical decisions and prevent patients from accessing potentially beneficial new therapies. This argument has revisionary implications for important and timely debates about medical paternalism, recreational drug legalization, human enhancement, prescription drug prices, physician assisted suicide, and pharmaceutical marketing. The need for reform is especially urgent as medical treatment becomes increasingly personalized and patients advocate for the right to try. The doctrine of informed consent revolutionized medicine in the twentieth century by empowering patients to make treatment decisions. Rights of self-medication are the next step.
Author: Lewis A. Grossman
Publisher: Oxford University Press
ISBN: 0190612770
Category : History
Languages : en
Pages : 352
Get Book Here
Book Description
A comprehensive history of the concept of freedom of therapeutic choice in the United States that presents a compelling look at how persistent but evolving notions of a right to therapeutic choice have affected American policy and law from the Revolution through the Trump Era. Throughout American history, lawmakers have limited the range of treatments available to patients, often with the backing of the medical establishment. The country's history is also, however, brimming with social movements that have condemned such restrictions as violations of fundamental American liberties. This fierce conflict is one of the defining features of the social history of medicine in the United States. In Choose Your Medicine, Lewis A. Grossman presents a compelling look at how persistent but evolving notions of a right to therapeutic choice have affected American health policy, law, and regulation from the Revolution through the Trump Era. Grossman grounds his analysis in historical examples ranging from unschooled supporters of botanical medicine in the early nineteenth century to sophisticated cancer patient advocacy groups in the twenty-first. He vividly describes how activists and lawyers have resisted a wide variety of legal constraints on therapeutic choice, including medical licensing statutes, FDA limitations on unapproved drugs and alternative remedies, abortion restrictions, and prohibitions against medical marijuana and physician-assisted suicide. Grossman also considers the relationship between these campaigns for desired treatments and widespread opposition to state-compelled health measures such as vaccines and face masks. From the streets of San Francisco to the US Supreme Court, Choose Your Medicine examines an underexplored theme of American history, politics, and law that is more relevant today than ever.
Author: Joseph Dumit
Publisher: Duke University Press
ISBN: 0822348713
Category : Business & Economics
Languages : en
Pages : 277
Get Book Here
Book Description
Challenges our understanding of health, risks, facts, and clinical trials [Payot]
Author: Ben Goldacre
Publisher: Macmillan
ISBN: 0865478066
Category : Business & Economics
Languages : en
Pages : 479
Get Book Here
Book Description
Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Author: Hirotaka Nonaka
Publisher: Nomos Verlagsgesellschaft
ISBN: 9783848752218
Category : Drug development
Languages : en
Pages : 0
Get Book Here
Book Description
Key features of innovation in the pharmaceutical industry -- How to achieve freedom to operate (FTO) -- Dealing with adverse patents -- Structure and operation of FTO-licensing markets in the parmaceutical industry -- FTO-licensing between a venture business company for innovative drug development and a pharmaceutical company.
Author: Annalee Newitz
Publisher: Tor Books
ISBN: 0765392070
Category : Fiction
Languages : en
Pages : 304
Get Book Here
Book Description
"When anything can be owned, how can we be free? Earth, 2144. Jack is an anti-patent scientist turned drug pirate, a pharmaceutical Robin Hood traversing the world in a submarine, fabricating cheap scrips for poor people who can't otherwise afford them. But her latest drug hack leaves a trail of lethal overdoses as people become addicted to their work, repeating job tasks until they become insane. Hot on her trail, an unlikely pair: Eliasz, a brooding military agent, and his partner, Paladin, a young indentured robot. As they race to stop information about the hacked drugs at their source, they form an uncommonly close relationship that neither of them fully understands, and Paladin begins to question their connection - and a society that profits from indentured robots" --
Author:
Publisher:
ISBN:
Category : Veterinary drugs
Languages : en
Pages : 144
Get Book Here
Book Description
Author: Diane Miller JD
Publisher: iUniverse
ISBN: 1663220204
Category : Political Science
Languages : en
Pages : 236
Get Book Here
Book Description
Diane Miller is a trusted leader and attorney in the national health freedom movement. She is the perfect person to inspire readers to activate health freedom. Miller, a Minnesota attorney, began her freedom work by helping to defend a dairy farmer who was prosecuted for helping people by giving them dairy colostrum. After a successful dismissal of charges, the author joined a band of Minnesota citizens who successfully advocated for a new law that protects healing and access to healers. In Health Freedom, the author takes a deep dive into the relationship between health and law, including the ways health freedom is in jeopardy. The stories will inspire you to contemplate: • What is health freedom? • How do we heal a world dominated by conventional science, medicine, and products? • What must we consider to keep ourselves healthy? Against the backdrop of COVID-19, the world is searching for answers about health and even survival. People want clarity on freedom, liberty, and the role of government in our lives. This book will be a foundational and inspiring read for health seekers and freedom lovers—and it could not come at a more critical time.
Author: David Herzberg
Publisher: University of Chicago Press
ISBN: 022673191X
Category : History
Languages : en
Pages : 372
Get Book Here
Book Description
The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer’s Heroin to Purdue’s OxyContin and all the drugs in between: barbiturate “goof balls,” amphetamine “thrill pills,” the “love drug” Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs called medicines are sold to a largely white clientele. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.
